Statins and PCSK9 inhibitors: A new lipid-lowering therapy
Enrique Gallego-Colón, Aner Daum, Chaim Yosefy
Topics & Concepts
EvolocumabPCSK9AlirocumabEzetimibeMedicineClinical trialStatinProprotein convertaseInternal medicineLDL receptorLipoproteinCholesterolApolipoprotein A1Lipoproteins and Cardiovascular HealthPharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life